SCHEMBL13284206

SCHEMBL13284206

Cc1cccc(-c2cccc(-c3cccc(-c4ccc(B(O)O)cc4)c3)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.57
▸ CA2 P00918 2/20 0.57
▸ CA1 P00915 1/20 0.57
▸ LPL P06858 1/20 0.50
▸ LIPG Q9Y5X9 1/20 0.50
▸ HSD17B1 P14061 2/20 0.44
▸ HSD17B2 P37059 2/20 0.44
▸ ENPP3 O14638 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ ESR1 P03372 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ DHODH Q02127 1/20 0.41
▸ ACHE P22303 2/20 0.41
▸ PGR P06401 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ PTPN5 P54829 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13284207 1.00 MGLL (0.57) MGLLCA2CA1LPLLIPG
SCHEMBL2700407 0.98 MGLL (0.59) MGLLCA2CA1LPLLIPG
SCHEMBL17899782 0.84 MGLL (0.67) MGLLCA2LPLLIPGACHE
SCHEMBL15458612 0.84 CA1 (0.82) MGLLCA2CA1HSD17B1HSD17B2
SCHEMBL20955808 0.84 CA1 (0.82) MGLLCA2CA1HSD17B1HSD17B2
SCHEMBL12419993 0.84 CA1 (0.82) MGLLCA2CA1HSD17B1HSD17B2
SCHEMBL30445177 0.84 CA1 (0.82) MGLLCA2CA1HSD17B1HSD17B2
SCHEMBL20840712 0.82 MGLL (0.76) MGLLCA2CA1HSD17B1HSD17B2
SCHEMBL29057032 0.81 ACHE (0.55) HSD17B1HSD17B2ENPP3MEN1ESR1
SCHEMBL30493472 0.81 ACHE (0.55) HSD17B1HSD17B2ENPP3MEN1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120267612-A1 CROSS-LINKABLE COPPER PHTHALOCYANINE COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2012-10-25 — — US disclosed
US-20120267612-A1 CROSS-LINKABLE COPPER PHTHALOCYANINE COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2012-10-25 — — US disclosed
WO-2010082924-A1 CROSS-LINKABLE COPPER PHTHALOCYANINE COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2010-07-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120267612-A1 CROSS-LINKABLE COPPER PHTHALOCYANINE COMPLEXES OCIAD1, OCIAD2, AOC2 MGLL 3454/4885CA2 2868/4885CA1 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback